Is annual review required for Class II medical device registration with ANVISA?
Release time:2024-11-06 14:08:38 The author: source:
Manufacturers must implement a post-market surveillance plan to monitor the safety and effectiveness of their devices once they are on the market. This involves collecting data on the device’s performance and any adverse events reported by users.

No, an annual review is not specifically required for Class II medical device registration with ANVISA (Agência Nacional de Vigilância Sanitária) in Brazil. However, there are several important compliance and oversight obligations that manufacturers must adhere to following registration:

Key Compliance Obligations After Registration

  1. Post-Market Surveillance:

    • Manufacturers must implement a post-market surveillance plan to monitor the safety and effectiveness of their devices once they are on the market. This involves collecting data on the device’s performance and any adverse events reported by users.
  2. Periodic Safety Reports:

    • Although not an annual review, manufacturers are often required to submit periodic reports on the safety and performance of their medical devices, especially if there are significant changes or safety concerns.
  3. Quality Management System (QMS) Compliance:

    • Manufacturers must maintain compliance with their Quality Management System (typically ISO 13485), which may require regular internal audits and management reviews to ensure continued adherence to quality standards.
  4. Registration Renewal:

    • Class II medical device registrations are typically valid for five years. Manufacturers must prepare for the renewal process well before the expiration date, which involves updating any necessary documentation and potentially resubmitting relevant data to ANVISA.
  5. Changes in Device or Manufacturing:

    • If there are significant changes to the device design, intended use, manufacturing process, or quality management system, manufacturers may need to submit a new application or an amendment to ANVISA for approval.
  6. Compliance with Regulatory Updates:

    • Manufacturers should stay informed about any changes to ANVISA regulations or guidelines that may affect their registered devices. Compliance with any new regulations is mandatory.

Conclusion

While there is no requirement for an annual review specifically for Class II medical device registration, manufacturers must actively engage in post-market surveillance and maintain compliance with regulatory standards and their quality management systems. They should also prepare for the five-year registration renewal process and address any changes in their devices or manufacturing practices as needed. If you have any more questions or need further clarification, feel free to ask!

pexels-daniel-frank-305568(3).jpg

Contact Us:

Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn